MOUNJARO TREATMENT AT CUTKILO
Our doctor-led approach ensures that your treatment is personalised and closely monitored at every step. From determining if Mounjaro is right for you to adjusting the dosage based on your progress, I will guide you through the process to maximise your results and safety.
Key Benefits
Dual hormone action:
Targets both GIP & GLP-1 receptors.
Convenient weekly dosing:
SELF-ADMINISTERED AT HOME VIA A PREFILLED INJECTION PEN JUST ONCE A WEEK
Effective appetite suppression:
Reduces hunger & cravings, helping control caloric intake.
Significant long-term weight loss:
WEIGHT REDUCTIONS OF 25+% OF TOTAL BODY WEIGHT
Reference: SURMOUNT-1 trial
https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
What to expect
Comprehensive initial consultation with Dr Emil to assess your medical history and goals.
Ongoing monitoring, including check-ins and any necessary adjustments.
Referral for blood tests to evaluate your health and monitor progress.
Support for incorporating lifestyle changes that enhance treatment effectiveness.
Revolution in pharmacotherapy happening today
Mechanism of action for Mounjaro (Tirzepatide)
A single-molecule GIP/GLP-1 receptor agonist enables therapeutic actions that are improved over the sum of GIP and GLP-1 single-receptor agonism.
Reference: a) Samms RJ, et al. Trends Endocrinol Metad 2020:31(6):410-421.
b) Bastin M, et al. Diabetes Metab Syndr Obes. 2019:12:1973-1985.
Liver
Improves liver health by reversing MASLD (fatty liver).
Stomach
Delays gastric emptying, making you feel fuller for longer.
Heart
Cuts cardiovascular risk by 20% (based on a large trial of 17,000 patients).
Brain
Reduces appetite and reduces cravings (potentially for alcohol too!), with some anecdotal evidence of improvement in migraines.
Pancreas
Increases insulin secretion and lowers blood sugar thus improving glucose control.
Adipose tissue (fat)
Increases insulin sensitivity, improves the unique ability of fats cells removing lipids from blood stream (called lipid-buffering capacity).
Whole-body (systemic)
Lowers blood glucose to normal range and reduces triglyceride levels.
Mounjaro is the latest advancement in weight-loss treatments and, in our view, one of the most effective options available following the success of Ozempic.
Unlike Ozempic, which targets only GLP-1 receptors, Mounjaro employs dual-action therapy by activating both GLP-1 and GIP receptors. This dual mechanism enhances its efficacy while offering the added benefit of fewer side effects for many patients.
How Mounjaro aids weight loss
Mounjaro works by increasing levels of two key hormones – GIP and GLP-1 – that help regulate insulin production and appetite. By activating both of these receptors, the medication offers a multifaceted approach to weight loss:
Appetite suppression
Mounjaro reduces hunger by slowing down gastric emptying, meaning food stays in the stomach longer. This promotes a feeling of fullness and reduces the frequency and amount of food consumed.
Reduced caloric intake
By influencing the brain's satiety centres, Mounjaro helps reduce cravings and the desire for high-calorie foods, making it easier to stick to a calorie-controlled diet.
Improved insulin sensitivity
For those with insulin resistance, Mounjaro helps regulate blood sugar levels more effectively, preventing blood sugar spikes that can lead to hunger and overeating.
Expected results & timeline
Throughout the program – access ongoing support from the CutKilo team to help you manage any side effects, optimise your lifestyle habits, and keep you accountable.
Weight Gain / Obesity
Weight gain and obesity are significant health issues that affect millions of people worldwide. Obesity refers to an excessive accumulation of body fat that poses a risk to health. In the UK, approximately 28% of adults are considered obese, according to…
Crunch the numbers with our BMI Calculator
*Enter your height and weight into our BMI calculator to estimate your healthy range and see how much weight you can safely lose. We’ll use this figure as a useful indication in your initial consultation.
If you have an Asian, Chinese, Middle Eastern, Black African or African-Caribbean family background you’ll need to use a lower BMI score to measure overweight and obesity:
- 23 to 27.4 -you’re in the overweight range
- 27.5 or above -you’re in the obese range
